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Abstract
Background: Evidence is mounting that area-level socioeconomic indicators are important tools for predicting
health outcomes. However, few studies have examined these alongside individual-level education. This nested
cohort study within the control arm of the United Kingdom Collaborative Trial of Ovarian Cancer Screening
(UKCTOCS) assesses the association of mutually adjusted individual (education) and area-level (Index of Multiple
Deprivation-IMD 2007) socioeconomic status indicators and all-cause female mortality.
Methods: Participants resident in England who had completed both baseline (Wave 1) and follow up (Wave 2)
questionnaires were included. Follow-up was through the Health and Social Care Information Centre with deaths
censored on 31st December 2012. IMD, education and a range of covariates were explored. Cox regression models
adjusted for all covariates were used. Sensitivity analysis using imputation was performed (1) including those with
missing data and (2) on the entire cohort who had completed the baseline questionnaire.
Results: Of the 54,539 women resident in England who completed both Wave 1 and Wave 2 questionnaires,
4,510 had missing data. The remaining 50,029 women were included in the primary analysis. Area-level IMD
was positively associated with all-cause mortality for the most deprived group compared to the least deprived
(HR=1.42, CI=1.14-1.78) after adjusting for all potential confounders. Sensitivity analyses showed similar results
with stronger associations in the entire cohort (HR=1.90, CI=1.68-2.16). The less educated an individual, the
higher the mortality risk (test for trend p=<0.001). However, the crude effect on mortality of having no formal
education compared to college/university education disappeared when adjusted for IMD rank (HR=1.08,
CI=0.93-1.26).
Conclusion: Women living in more deprived areas continue to have higher mortality even in this less deprived
cohort and after adjustment for a range of potential confounders.
Trial Registration: This study is registered as an International Standard Randomised Controlled Trial, number
ISRCTN22488978.
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Background
It has been repeatedly shown that socioeconomic status can
have a detrimental effect on health. [1-6] Socioeconomic dif-
ferences in health outcomes including mortality are one of
the most consistent findings in epidemiology [7]. Income
[8,9], occupation [10,11], and education [12-14] are all
among major determinants of population distribution of
health. More recently, researchers have become increasingly
interested in area-level socioeconomic indicators of health
inequalities and in whether they play a role over and above
individual-level socioeconomic indicators [15-22]. Data used
for such analyses are often of insufficient size. Multi-level
analysis focusing on the role of socioeconomic determinants
of mortality (both all-cause and cause-specific) is rare [19].
This has resulted in growing consensus for the need of
multi-level analysis in data from larger cohorts [15,23-25].
We report on the association between individual-level edu-
cation and area-level measures of social position and all-
cause and cause-specific mortality in women aged 50–74
years in the control arm of the United Kingdom Collabora-
tive Trial of Ovarian Cancer Screening (UKCTOCS) adjust-
ing for a range of individual-level covariates, health
behaviours and comorbidity. The advantage of this analysis
is that it uses recent data from 2001–12 and is of larger size
than other UK and most European-based studies on the
relative role of individual-level education and area-based
measures of socioeconomic position. The aim of the study is
to assess whether there are associations between area-level
deprivation and mortality over and above individual-level
socioeconomic measures.
Methods
UKCTOCS is a randomised controlled trial set in 13
National Health Service Trusts in England, Wales and
Northern Ireland. The aim is to assess the impact of screen-
ing on ovarian cancer mortality by comparing participants
randomised to annual screening with serum CA125 or
transvaginal ultrasound (study arm) to those with no inter-
vention (control arm) [26]. Inclusion criteria were age (50–
74) and postmenopausal status. Exclusion criteria included
bilateral oophorectomy, increased risk of familial ovarian
cancer, previous ovarian malignancy, active non-ovarian
malignancy and participation in other ovarian cancer
screening trials. The study was approved by the UK North
West Multicentre Research Ethics Committees (North
West MREC 00/8/34) along with site specific approval from
the local regional ethics and the Caldicott guardians of the
primary care trusts [27]. Written informed consent was
obtained from all volunteers.
Between 2001 and 2005, 1,243,312 women were invited
at random from those that were eligible from 27 local
health authority registers [27]. These were located around
13 regional centres – Belfast, Bristol, Cardiff, Derby, Gates-
head, Liverpool, Manchester, Middlesbrough, North Wales,
Nottingham, Portsmouth, Royal Free and St Bartholomew’s
Hospitals in London. Potential participants were sent invita-
tions to participate. If they accepted, they were given an ap-
pointment at a local trial centre where they viewed an
information video, participated in a group discussion and
had a private, one to one session with a research nurse be-
fore signing the consent form. The overall acceptance rate
was 24.8% [27] with 202,638 women successfully recruited
[26]. Only women residing in England were included in this
analysis.
Participants completed a baseline questionnaire when
they entered the study (Wave 1) and were sent a follow−up
questionnaire approximately 3.5 years later (Wave 2). The
baseline questionnaire included questions on medical his-
tory, demographic and physical characteristics whilst the
follow up questionnaire included questions on medical his-
tory, education, lifestyle (including alcohol consumption
and smoking habits) and outlook on life. Index of Multiple
Deprivation (IMD) 2007 [28] was calculated using the post
code. The IMD is made up of 7 domains in which 38 indi-
cators, appropriately weighted, are used to calculate a
deprivation score. Each postcode has its own individual
score. The volunteers’ deprivation scores, varying from 0.72
to 85.46, were divided into six groups ranging from the
least deprived to the most deprived.
All volunteers were flagged for cancer registrations/
deaths through the appropriate national agency, the Health
and Social Care Information Centre (HSCIC). The updated
cancer registration listings for this analysis were received on
3rd June 2013. Death registration and cause of death infor-
mation was obtained from HSCIC every quarter and the
dataset updated accordingly. Cause of death was recorded
using the World Health Organisation’s International Classi-
fication of Diseases 10th revision (ICD10). In the UK, ma-
jority of the deaths are registered within three months,
hence events were censored on the 31st December 2012,
3 months prior to the last death certificates update in
March 2013 from HSCIC.
Variables
STATA 12 statistical package was used for the analysis.
Participants in this nested cohort study were women in
the control group (to ensure that screening undertaken in
the trial had no impact on mortality) who were resident
in England (as the IMD 2007 [28] excludes Wales and
Northern Ireland). The Northern Ireland Deprivation
Measure 2010 [29] and the Welsh IMD 2008 [30] have not
been used, as the differing criteria between the three mea-
sures would make comparisons untenable. As the education
exposure variable was only included in the follow up ques-
tionnaire, participants who completed the baseline question-
naire but not the follow up questionnaire were excluded.
The main outcome was all-cause mortality during the
study period. Additional outcomes were ‘cardiovascular
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disease’ (CVD) and ‘cancer’ specific mortality. Cause of
death was recorded using the ICD10–‘Ischaemic heart
disease and diseases of the circulatory system’ and ‘Neo-
plasms’ respectively. Variables explored were IMD, age,
ethnicity, Hormone Replacement Therapy (HRT) use,
Body Mass Index (BMI) collected at Wave 1 and educa-
tion, alcohol consumption, smoking, change in partici-
pants skirt size between their early 20’s and on
completion of the follow-up questionnaire, being or hav-
ing been treated for any of the following conditions; high
blood pressure, heart disease, high blood cholesterol,
diabetes, rheumatoid arthritis, osteoarthritis, stroke,
osteoporosis, or none of the above conditions collected
at Wave 2. Participants with missing data on covariates,
miscoded height (<120 cm and >210 cm) and weight
(<30 kg and >200 kg) or incorrect dates (i.e. follow-up
questionnaire completion date or death date that pre-
ceded the date the follow up questionnaire was printed)
were excluded.
Baseline characteristics of the study participants were ex-
amined. 95% confidence intervals were used throughout.
The date of study entry was the date that the completed
follow-up questionnaire was received by the Gynaecological
Cancer Research Centre (GCRC), University College
London (UCL) (or date printed, in the event where the date
received had not been recorded). The date of study exit was
censored on the 31 December 2012 or the death date as
provided by HSCIC. A follow up time was created for those
who completed the follow up questionnaire, from the study
entry date to study exit date.
Statistical analysis
Mortality rates for all covariates were calculated and the
statistical significance of the association between covari-
ates and mortality was assessed. A Cox regression model
was used to analyse the hypotheses, [1] those living in
more deprived areas in England will have a higher mor-
tality risk than those living in less deprived areas and [2]
those with lower educational attainment will have a
higher mortality risk than those with higher educational
attainment.
The regression models were then adjusted for age and all
other covariates from the baseline and follow-up question-
naires. Country of birth was not included as it did not have
a statistically significant association with mortality. To ac-
count for potential geographical clustering (within-cluster
correlation) of the data, standard errors were calculated
using a cluster-robust estimator. Geographic clusters were
defined using the Super Output Area 1 codes [31], linked
to provided postcodes, resulting in 6954 clusters. A test for
trend was performed on all models and interaction between
the main exposures of education and IMD was assessed
using the likelihood-ratio test. The Kaplan-Meier method
was used to obtain survival curves to compare the death
rates by education and IMD. The least deprived group of
IMD rank and those with college or university education
were used as the reference categories for all regression
analyses.
Further analysis was done for cancer and CVD mortal-
ity. The relationship between education and IMD rank
and CVD and cancer was analysed using Cox regression.
The regression models were adjusted for age and a test
for trend was performed.
Sensitivity analysis was performed on [1] the entire
English cohort who had completed the baseline question-
naire using the smaller number of variables available (Wave
1) and [2] participants who had completed the follow-up
questionnaire including those with missing and miscoded
data (Wave 2). Multiple imputation of the missing data was
performed because sensitivity analysis did not show any
substantial differences in distribution of covariates among
those with no missing data and those with some missing
data. Ten imputations were considered sufficient and 10
imputed datasets were produced using the multiple imput-
ation command in STATA version 12. Appropriate com-
mands relevant for imputed data were then used in the
regression analysis.
Results
There were 79,006 participants in the UKCTOCS con-
trol group who were resident in England. 54,539 com-
pleted both baseline and follow-up questionnaires. 4510
were excluded due to incorrect dates (653), missing data
(3,395) and miscoded height and weight (462). The
remaining 50,029 women were included in the final ana-
lysis (Figure 1).
The characteristics of the study participants are de-
tailed in Table 1. All were resident in England but only
89.5% were born in England with the remaining 2.1%
born in Scotland, 1.4% in Wales, 0.5% Northern Ireland,
1.3% in Irish Republic and 5.3% elsewhere. The median
age was 60 (interquartile range 10) and 98% were Cauca-
sian. The median BMI was 26. Twenty percent had been
educated to college or university level. Sixty five percent
of women were in the least two deprived categories of
the six deprivation categories.
All-cause mortality
All associations between all-cause mortality and covari-
ates were statistically significant with p-values <0.05,
with the exception of country of birth.
All-cause mortality rate decreased with education (7.9
per 1000 person years for those with no formal educa-
tion beyond 16 years versus 4.7 per 1000 person years
for those with a college or university degree) (Additional
file 1: Table S1). The crude association between educa-
tion and mortality was statistically significant (p=<0.001
for those with no formal education) but when adjusted
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for all covariates this relationship was no longer significant
(p=0.1) for those with no formal education) (Additional
file 1: Table S2). A clear dose response relationship
remained with hazard ratios from 1.04 and 1.13 for other
formal education and no formal education respectively. A
test for trend was statistically significant providing evi-
dence that the less educated the individual, the higher the
risk of mortality (p=<0.001).
All-cause mortality rate increased with IMD rank (5.1 per
1000 person years for the least deprived group versus 8.4
per 1000 person years for the most deprived group)
(Additional file 1: Table S1). The crude association between
IMD rank and mortality was significant (p=<0.001 for the
most deprived group) and when adjusted for all covariates
this relationship remained significant (p=0.001 for the most
deprived group) with a hazard ratio of 1.45 for the most de-
prived group (Additional file 1: Table S3). A test for trend
was significant (p=<0.001) providing evidence that the risk
of mortality increases with deprivation.
Table 1 shows the association between education, IMD
rank and mortality when education and IMD rank were en-
tered simultaneously into a regression model. After adjust-
ing for all the covariates, education was no longer significant
whilst IMD rank remained significant (HR 1.42 for the most
deprived group; p = 0.004) with a clear gradient.
The Kaplan-Meier survival curves (Figures 2 and 3) show
no difference in survival for either IMD or education. There
is a clear gradient in survival by education and clear
differentiation between the three less deprived and the three
more deprived IMD groups. Proportionality was tested
using the Schoenfeld residuals test and the proportional
hazards assumption was not violated (p=0.256).
Cancer mortality
Crude analysis between volunteers with no formal educa-
tion compared to those with education and after adjusting
for age, no formal education was significant (p=0.041 for
those with no formal education), as was the test for trend
(p=0.024). Age adjusted analysis for no formal education
compared to college/university education had a hazard ratio
of 1.22. The association between IMD rank and cancer
mortality was also significant (p=0.012 for the most de-
prived group). For the most deprived group the age ad-
justed hazard ratio was 1.59 (p=0.002) and there was a
significant dose response relationship between IMD rank
and cancer mortality (p=0.001) (Additional file 1: Table S4).
Table 2 shows the mutually adjusted analysis model for
the association between education, IMD rank and cancer
mortality. Education was no longer significant (p=0.187 for
those with no formal education) but there was a significant
gradient (p=<0.001) with a hazard ratio of 1.14 for those
with no formal education compared to those with college/
university education. While the IMD rank only remained
significant for groups 4, 5 and 6, the test for trend was sig-
nificant (p=0.003). For the most deprived group, the age ad-
justed hazard ratio was 1.58 (p=0.005).
Figure 1 Derivation of the analytical sample.
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Table 1 The association between all-cause mortality, education, IMD rank and all other variables in a mutually adjusted
model, n=50,029
Number % HR (95% CI) P-value P-value for trend
Education Level
College/University 10300 20.6 1.00 <0.001
Other formal qualification 24689 49.4 1.04 (0.90-1.20) 0.580
No formal qualification 15040 30.1 1.08 (0.93-1.26) 0.334
IMD Rank
1=Least deprived (0–9) 16672 33.3 1.00 <0.001
2 (10-19) 16950 33.9 1.14 (1.00-1.30) 0.048
3 (20-29) 7797 15.6 1.10 (0.94-1.29) 0.230
4 (30-39) 4212 8.4 1.44 (1.21-1.72) <0.001
5 (40-49) 2317 4.6 1.42 (1.14-1.77) 0.002
6=Most deprived (50+) 2081 4.2 1.42 (1.12-1.81) 0.004
Age 1.10 (1.09-1.11) <0.001 -
Ethnicity
White 48904 97.8 1.00 -
Black 442 0.9 0.85 (0.48-1.51) 0.579
South Asian 257 0.5 0.14 (0.20-1.00) 0.05
Other 426 0.9 0.56 (0.25-1.25) 0.158
BMI Kg/M2 (Continuous) 1.00 (0.99-1.01) 0.872 -
BMI Categories Kg/M2
Normal (20-24) 20,385 40.75 1.00 0.012
Underweight (11-19) 1,866 3.73 1.20 (0.94-1.53) 0.149
Overweight (25-29) 18,376 36.73 0.95 (0.84-1.07) 0.374
Obese (30-39) 8,660 17.31 1.00 (0.85-1.17) 0.983
Morbidly Obese (40+) 742 1.48 1.46 (1.03-2.07) 0.033
HRT (Current at baseline) -
No 9858 19.7 1.00
Yes 40171 80.3 1.05 (0.92-1.20) 0.491
Current Alcohol use (units per week)
None 11242 22.5 1.00 <0.001
Less than 1 unit 8741 17.5 0.90 (0.77-1.03) 0.127
1-3 units 10288 20.6 0.71 (0.61-0.83) <0.001
4-6 units 7603 15.2 0.73 (0.62-0.86) <0.001
7-10 units 6052 12.1 0.67 (0.56-0.82) <0.001
11+ units 6103 12.2 0.83 (0.70-1.00) 0.049
Skirt size difference
No change 215 0.4 1.00 0.181
+1-2 sizes 3,226 6.5 0.97 (0.84-1.12) 0.690
+3 or more sizes 8743 17.5 1.07 (0.89-1.29) 0.485
−1-2 sizes 30,093 60.2 1.60 (1.30-1.96) <0.001
−3 or more sizes 7,752 15.5 1.20 (0.62-2.34) 0.592
Ever smoked -
No 27849 55.7 1.00
Yes 22180 44.3 1.57 (1.42-1.74) <0.001
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CVD mortality
Crude analysis comparing volunteers with no formal educa-
tion compared to those with education and after adjusting
for age, no formal education was statistically significant
(p=0.034 for those with no formal education), as was the
test for trend (p=0.008). Age adjusted analysis for no formal
education had a hazard ratio of 1.44. The association be-
tween IMD rank and CVD mortality showed a clear dose
response relationship. The test for trend was significant
(p=<0.001) and hazard ratio for the most deprived group
compared to the least deprived group was 1.63 after adjust-
ing for age (Additional file 1: Table S5).
Table 1 The association between all-cause mortality, education, IMD rank and all other variables in a mutually adjusted
model, n=50,029 (Continued)
History of high blood pressure -
No 33979 67.92 1.00
Yes 16050 32.08 1.13 (1.01-1.26) 0.035
History of heart disease -
No 47209 94.36 1.00
Yes 2820 5.64 1.52 (1.30-1.79) <0.001
History of high blood cholesterol -
No 37898 75.75 1.00
Yes 12131 24.25 0.80 (0.71-0.90) <0.001
History of diabetes -
No 47484 94.91 1.00
Yes 2545 5.09 1.48 (1.24-1.77) <0.001
History of rheumatoid arthritis -
No 47626 95.2 1.00
Yes 2403 4.8 1.12 (0.93-1.36) 0.231
History of osteoarthritis -
No 41678 83.31 1.00
Yes 8351 16.69 0.98 (0.86-1.11) 0.720
History of stroke -
No 49268 98.48 1.00
Yes 761 1.52 1.71 (1.33-2.22) <0.001
History of osteoporosis
-No 46359 92.66 1.00
Yes 3670 7.34 1.28 (1.09-1.49) 0.002
Figure 2 Kaplan-Meier survival estimates for education. Figure 3 Kaplan-Meier survival estimates for IMD.
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Table 3 shows the mutually adjusted analysis model for
the association between education, IMD rank and CVD
mortality. Education is no longer statistically significant
(p=0.134 for those with no formal education) but the test
for trend was significant (p=<0.001) showing a social gradi-
ent and a hazard ratio of 1.30 for those with no formal edu-
cation compared to those with college/university education.
IMD rank showed a significant trend (p=0.018) towards in-
creasing mortality but only groups 3 and 4 remained signifi-
cant (p=0.001 and p=<0.001 respectively). For the most
deprived group the age adjusted hazard ratio was 1.48
(p=0.199).
Sensitivity analysis
Missing data for all variables was 8.3%. Sensitivity analyses
looking at the entire cohort (79,006) and those who had
completed the follow-up questionnaire (53,886) showed
similar proportions to the study sample (50,029). Mortality
rates were similar as were the results of Cox regression al-
though the associations were stronger and the confidence
intervals smaller in the analysis involving the entire cohort
(79,006). This was most likely due to the larger sample size
and longer follow-up time resulting in a larger number of
person-years available for analysis.
Discussion
Summary of findings
This is one of the largest studies examining the association
between individual-level education and area-level indicators
of socioeconomic position and all-cause and cause-specific
mortality that we are aware of. Our analysis of over 50,000
older women residing in the UK between 2001–12 found
both IMD rank and education to be positively associated
with all-cause mortality with a clear dose response relation-
ship. IMD rank remained positively associated with all-
cause mortality after taking into account a wide range of
potential confounders such as age, smoking, alcohol con-
sumption, BMI, co-morbidities and mutually adjusting for
education. There was a clear gradient even within the con-
text of a screening trial with a significant ‘healthy volunteer
effect’ [26] with the hazard ratio for all-cause mortality for
those living in the most deprived areas (1.42) being higher
than reported in previous studies. The survival curves
(Figures 2 and 3) suggest that neither educational nor IMD
differences in survival converge at later years of the study
Table 2 The association between cancer mortality, education and IMD rank in a mutually adjusted model, n=50,029
Education Level Model adjusted for age HR (95% CI) P-value P-value for trend
College/University 1.00 <0.001
Other formal qualification 1.06 (0.89-1.27) 0.512
None 1.14 (0.94-1.38) 0.187
IMD rank Model adjusted for age HR (95% CI) P-value P-value for trend
1=Least deprived (0–9) 1.00
0.003
2 (10-19) 1.16 (0.98-1.36) 0.082
3 (20-29) 1.10 (0.90-1.36) 0.352
4 (30-39) 1.35 (1.06-1.71) 0.013
5 (40-49) 1.65 (1.25-2.16) <0.001
6=Most deprived (50+) 1.58 (1.14-2.08) 0.005
Table 3 The association between cardiovascular disease mortality, education and IMD rank in a mutually adjusted
model, n=50,029
Education Level Model adjusted for age HR (95% CI) P-value P-value for trend
College/University 1.00 <0.001
Other formal qualification 1.02 (0.73-1.42) 0.923
None 1.30 (0.92-1.82) 0.134
IMD rank Model adjusted for age HR (95% CI) P-value P-value for trend
1=Least deprived (0–9) 1.00
0.018
2 (10-19) 1.32 (0.97-1.79) 0.075
3 (20-29) 1.76 (1.25-2.47) 0.001
4 (30-39) 2.32 (1.60-3.39) <0.001
5 (40-49) 1.40 (0.81-2.42) 0.224
6=Most deprived (50+) 1.48 (0.81-2.69) 0.199
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(when populations get older). We also found a statistically
significant inverse trend with CVD mortality and all cancer
mortality after adjusting for individual-level education. The
results support increasing evidence that place of residence
of individuals affects their health, [16,17,32,33] and that the
IMD scale can be an effective tool to assess this effect.
Strengths and limitations
A key strength of our study is that unlike previous studies
which only examined education (individual-level variable) or
IMD rank (area-level variable) as indicators of deprivation,
we used both and therefore were able to account for individ-
ual social circumstances and area-level deprivation. We were
able to adjust for a large number of individual-level factors
such as BMI, comorbidity, smoking and alcohol use unlike
analyses using national statistics. The scale of this analysis of
50,029 women was significantly larger than comparable pre-
vious studies with sample sizes ranging from 1,811–31,264
[13,25]. The fact that IMD was obtained from an external
source while education was collected through postal ques-
tionnaire from trial participants and the large number of
clusters (6954) ensured that the choice of method account-
ing for clustering of data did not substantially influence the
finding, allowing a separation between the effects of IMD
and education. An additional methodological strength was
low proportion of missing data (8.3%). Sensitivity analysis
was undertaken with imputation of the missing results as
well as inclusion of the entire cohort (79,006) including
those who had only completed the baseline questionnaire
(24,467) with no change in results.
Certain design characteristics of our screening trial need
to be considered when interpreting the current findings.
While almost 1 million women were randomly invited
from ‘age/sex’ registers of 27 health authorities [27], those
that participated may not be entirely representative of the
women living in England. Health authorities in the North
East and South West England were not included as there
were no trial centres in these regions. Our cohort seems
to be somewhat different from the general population with
97.8% white participants compared to 85.5% of the UK
population [34]. Alcohol consumption and smoking were
also much higher in our cohort. Alcohol consumption (>7
units per week) was 40.4% compared to 19% (in women
aged 45–64) or 6% (aged over 65) and smoking was 44.3%
versus 37% in the UK population (all ages) [35,36]. The
IMD scores of the invitees were higher than the national
average, possibly due to an over-representation of urban
centres [26]. This indicates that the 50,029 (17.3%) of
those eligible and willing to participate, and included in
this nested cohort study, were less deprived which could
potentially bias the study. A significant ‘healthy volunteer
effect’ has been reported on this cohort [26] which could
have led to an underestimation of the impact of area-level
deprivation on mortality. In addition, underestimation
might have also resulted from inclusion of the variables in
the models as confounders when they were at least in part
mediators. For example, deprivation may well impact on
mortality, in part, through greater access to fast food, alco-
hol and tobacco outlets, encouraging poor health choices,
which in turn cause comorbidity and ultimately lead to
higher death rates. Education was the only available indi-
cator of personal deprivation in UKCTOCS. There is con-
troversy whether education alone without income data is a
sound indicator of individual deprivation [14,37,38].
The use of the Index of Multiple Deprivation as a pre-
dictor of health has been debated. However, the English
IMD 2007 used in this analysis has been developed over
the years to a high standard. It has seven complex and
multifaceted domains - income and employment each
contributing to 22.5% of the IMD score; barriers to hous-
ing/services, crime and living environment 9.3% each; and
education and health deprivation/disability 13.5% each.
While the ‘health deprivation/disability’ domain is based
on years of potential life lost, comparative illness and dis-
ability ratio, measures of acute morbidity and the propor-
tion of adults under 60 suffering from mood/anxiety
disorders [39] and could contribute to the association be-
tween IMD rank and mortality, as is clear from above, it
only contributes to a tenth of the score. It would have
been interesting and useful to look at each domain separ-
ately but linkage to this data was not possible. Full multi-
level analysis is probably the most appropriate method to
answer the question of whether there are associations be-
tween area-level deprivation and mortality over and above
individual-level measures. However, multilevel Cox regres-
sion using multiply imputed data was not possible in the
current version of the statistical software available to the
authors. We accounted for potential geographical cluster-
ing of the data by calculating standard errors using a
cluster-robust estimator. We believe that this method, to-
gether with the large number of clusters, ensured that
clustering did not substantially influence the results and
we were able to separate between the effects of IMD and
education.
Area-level deprivation and mortality
Our study’s results show a strong association between
area-level deprivation expressed by IMD and all-cause
mortality which is in line with previous findings
[40,41]. Multiple domains of IMD might represent sev-
eral possible explanations and mechanisms that can
link social disadvantage and mortality including differences
in wealth and income, risky health behaviours, access to
healthcare and treatment, accumulation of social disadvan-
tage in different stages of lifecourse or psychosocial factors
such as control, autonomy or trust [42]. IMD rank showed
a dose response relationship on subgroup analysis of cancer
and cardiovascular disease mortality, with the magnitude of
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effect increasing as deprivation score increased. There is
much evidence to support the concept that socioeconomic
status [43-45] and area-level measures of deprivation
[46,47] are related to cancer survival. The association with
cardiovascular mortality was not significant although there
was a clear gradient in keeping with other reports [48-50].
The non-significant results may be due to the relatively low
number of cause-specific deaths. In our cohort (median age
60) there were approximately three cancer deaths to every
CVD death, in keeping with recent national statistics which
report cancer to be the leading cause of death in those aged
below 85 [51,52].
Individual-level education and mortality
While education showed a clear social gradient with all-
cause mortality in keeping with previous literature,
[13,14,37,38,53,54] when mutually adjusted for IMD rank, a
reduced, non-significant effect was seen (although p for
trend remained significant probably due to the large sample
size). This is in contrast to most other studies where educa-
tion was found to be a significant predictor of mortality.
However, our findings in older women are in keeping with
those of Steenland et al. [19] who found that in multivari-
able analysis of a large US sample, education remained an
important predictor only among men but not women.
Others have also reported a weak association of education
with mortality among women [55-57]. Variations in educa-
tion level could result in variations in mortality through
both access to higher paying occupations and through
health literacy.
Conclusions
Our data from UKCTOCS emphasises the importance of
considering area-level indicators of socioeconomic status
and supports the hypothesis that those living in more de-
prived areas in England have higher all-cause and cause-
specific mortality rates than those living in less deprived
areas. There may be several reasons for this - area-level in-
dicators may capture community characteristics that play
a role in mortality or residual confounders not adequately
characterized by individual-level variables. Our analysis
highlights the continued need to improve community ser-
vices and living environments in deprived areas in order
to reduce health inequality. As a recent Lancet editorial
[58] points out, prioritising social protection in the midst
of austerity is key to preventing a financial recession be-
coming a health recession.
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